These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4357309)

  • 1. Immunofluorescent antigen associated with Epstein-Barr virus induced by 5-Iododeoxyuridine.
    Sugawara K; Osato T
    Nat New Biol; 1973 Nov; 246(151):72-3. PubMed ID: 4357309
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of Epstein-Barr virus-related membrane antigens by 5-iododeoxyuridine in non-producer human lymphoblastoid cells.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1973 Nov; 246(151):70-2. PubMed ID: 4357308
    [No Abstract]   [Full Text] [Related]  

  • 3. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
    Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
    Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.
    Derge JG; Martos LM; Tagamets MA; Chang SY; Chakrabarty M
    Nat New Biol; 1973 Aug; 244(137):214-7. PubMed ID: 4353682
    [No Abstract]   [Full Text] [Related]  

  • 5. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
    Sugawara K; Osato T
    Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
    Simonová I; Závadová H; Vonka V
    Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.
    Glaser R; Nonoyama M; Decker B; Rapp F
    Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers.
    Moar MH; Siegert W; Klein G
    Intervirology; 1978; 9(6):333-43. PubMed ID: 204604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time of synthesis and cellular location of Epstein-Barr virus-specified polypeptides radioimmunoprecipitated from iododeoxyuridine-induced Burkitt lymphoma/somatic cell hybrids.
    Durnford JM; Scanlon PA; Glaser R
    J Gen Virol; 1982 May; 60(Pt 1):39-48. PubMed ID: 6284867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of Epstein-Barr virus-associated antigens in infected Raji cells.
    Gergely L; Klein G; Ernberg I
    Virology; 1971 Jul; 45(1):10-21. PubMed ID: 4329584
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

  • 14. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment.
    Shapiro IM; Andersson-Anvret M; Klein G
    Intervirology; 1978; 10(2):94-101. PubMed ID: 209000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the arginine analog canavanine on the synthesis of Epstein-Barr virus-induced proteins in superinfected Raji cells.
    Bayliss GJ; Wolf H
    J Virol; 1982 Mar; 41(3):1109-11. PubMed ID: 6284966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the resistance of Fpstein-Barr virus DNA synthesis to hydroxyurea.
    Mele J; Glaser R; Nonoyama M; Zimmerman J; Rapp F
    Virology; 1974 Nov; 62(1):102-11. PubMed ID: 4371583
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of an Epstein-Barr virus-induced DNA polymerase.
    Miller RL; Glaser R; Rapp F
    Virology; 1977 Feb; 76(2):494-502. PubMed ID: 14436
    [No Abstract]   [Full Text] [Related]  

  • 19. Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Rapp F
    J Virol; 1972 Aug; 10(2):288-96. PubMed ID: 4342246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedure for activating Epstein-Barr virus early antigen in nonproducer cells by 5-iododeoxyuridine.
    Long C; Derge JG; Hampar B
    J Natl Cancer Inst; 1974 Apr; 52(4):1355-7. PubMed ID: 4363712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.